Related Experiment Videos

Differing prognostic significance of reinfection and relapse in CAPD peritonitis

W al-Wali1, R Baillod, W Brumfitt

  • 1Department of Medical Microbiology, Royal Free Hospital, London, UK.

Insights

Differentiating between relapse and reinfection in Continuous Ambulatory Peritoneal Dialysis (CAPD) peritonitis is crucial. Relapse indicates a poorer prognosis, with lower antibiotic treatment response and higher catheter removal rates compared to reinfection.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Medical Microbiology

Background:

  • Recurrent infections in Continuous Ambulatory Peritoneal Dialysis (CAPD) units pose a significant challenge.
  • Distinguishing between relapse and reinfection is critical for accurate prognosis and management.
  • Previous studies have not clearly defined the differential prognostic importance of relapse versus reinfection in CAPD peritonitis.

Purpose of the Study:

  • To analyze episodes of recurrent infection in a CAPD unit over 26 months.
  • To determine if relapse and reinfection have different prognostic implications.
  • To assess the impact on treatment outcomes and Tenckhoff catheter survival.

Main Methods:

  • Analysis of all recurrent infection episodes in a CAPD unit over a 26-month period.
  • Microbiological investigations to differentiate between relapse and reinfection.
  • Prognostic assessment based on treatment response and catheter fate.

Main Results:

  • Twenty-nine patients experienced recurrent infections; 9 had relapses, and 20 had reinfections.
  • Patient characteristics were similar between relapse and reinfection groups.
  • Relapse was associated with significantly poorer outcomes: lower antibiotic response (20% vs. 78%) and higher catheter removal rates (78% vs. 10%) compared to reinfection.

Conclusions:

  • Differentiating relapse from reinfection in CAPD peritonitis is essential for patient management.
  • Relapse carries a graver prognosis than reinfection.
  • Accurate differentiation is vital for interpreting therapeutic trial results correctly.

Related Concept Videos